Alpine Global Management, LLC Aravive, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$4.7 - $12.06 $122,021 - $313,101
-25,962 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$5.18 - $14.81 $669,416 - $1.91 Million
-129,231 Reduced 83.27%
25,962 $302,000
Q1 2020

Apr 09, 2020
BUY
$3.5 - $13.77 $187,015 - $735,772
53,433 Added 52.51%
155,193 $894,000
Q4 2019

Jan 16, 2020
BUY
$6.21 - $14.02 $631,929 - $1.43 Million
101,760 New
101,760 $1.39 Million

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email